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Edited by Irmgard SinningAbstract Complement activity in mammalian serum is funda-
mentally based on three homologous components C3b, C4b and
C5. During systemic infection, the gastrointestinal pathogen Sal-
monella enterica disseminates within host phagocytic cells but
also extracellularly. Consequently, systemic Salmonella tran-
siently confronts the complement system. We show here that
the surface protease PgtE of S. enterica proteolytically cleaves
C3b, C4b and C5 and that the expression of PgtE enhances bac-
terial resistance to human serum. Degradation of C3b was fur-
ther enhanced by PgtE-mediated plasminogen activation.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The human complement is a complex system of plasma pro-
teins and plays amajor role in resistance againstmicrobial infec-
tions, as it participates in both innate and speciﬁc immunity [1].
Activation of the complement cascade leads to opsonization of
foreign microbes, release of chemotactic peptides, and ﬁnally to
disruption of bacterial cell membranes [2]. Three homologous
glycoproteins in the complement system, C3, C4 and C5, play
a central role in complement function and interact with numer-
ous other complement components [3]. C3b and C4b, generated
from C3 and C4, are important components of convertases that
promote activation of the complement cascade. The cleavage
fragments of C5 are C5a, which induces migration of phago-
cytes into the infection site, and C5b, which initiates the forma-
tion of the membrane attack complex and bacterial lysis [2].
Salmonella enterica serovar Typhimurium is a common
food-borne pathogen that mainly causes gastroenteritis in the
small intestine, yet approximately 5% of infected humans de-
velop bacteraemia [4]. Typhimurium infection in mice, on the
other hand, resembles human typhoid fever, which is a severe
systemic infection caused by S. enterica serovar Typhi [5]. The
systemic dissemination of Salmonella from the gastrointestinal
tract to the liver and the spleen takes place mainly within in-
fected macrophages and dendritic cells [6]. The survival and
growth of Salmonella inside these cells is supported by forma-
tion of a speciﬁc Salmonella-containing vacuole that avoids fu-*Corresponding author. Fax: +358 9 19159262.
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infected macrophages [9], and during the systemic infection
of S. enterica serovar Typhi, one-third of the bacterial cells
are not associated with phagocytic host cells [10]. This suggests
the release of salmonellae from macrophages during infection
and, at least transient, extracellular dissemination.
The lipopolysaccharide (LPS) in clinical isolates of Salmo-
nella has long O-antigen oligosaccharide chains. O-antigen is
a major determinant in serum resistance of salmonellae [11,1].
However, during growth of S. enterica serovar Typhimurium
within mouse macrophages, the LPS structure is altered and
the length and the amount of the O-antigen are strongly re-
duced [12,13]. Therefore, other mechanisms for complement
resistance probably are needed after release of Salmonella from
macrophages, when it is likely to confront complement attack.
The surface protease PgtE of S. enterica belongs to the omp-
tin family of enterobacterial outer membrane aspartate prote-
ases [14]. PgtE and other omptins require rough LPS to be
active but are sterically inhibited by the O-antigen [15,16].
Expression of PgtE is upregulated during growth of Salmonella
inside macrophages [12,13] and the bacteria released from
macrophages exhibit a strong PgtE-mediated proteolytic activ-
ity [13]. PgtE proteolytically activates the mammalian plasma
proenzyme plasminogen to plasmin [17], inactivates the main
physiological inhibitor of plasmin, a2-antiplasmin [13], and
mediates bacterial adhesion to extracellular matrices of human
cells [16]. This way, PgtE mediates degradation of extracellular
matrix components and generates potent, localized proteolytic
activity, which may promote migration of Salmonella across
extracellular matrices. PgtE also degrades alpha-helical antimi-
crobial peptides [18], which may be important during intracel-
lular growth of Salmonella.
The omptin Pla of Yersinia pestis is a close ortholog of PgtE
and shares functions with PgtE [16,17,19]. P1a cleaves C3 [20],
and we therefore assessed PgtE for cleavage of complement
components and protection against complement-mediated kill-
ing of bacteria. Our results suggest that PgtE increases serum
resistance of Salmonella by cleaving complement components
C3b, C4b and C5.2. Materials and methods
2.1. Complement components
Puriﬁed human complement components C4b, C5, factor H and fac-
tor I were obtained from Calbiochem. C4bp and C3 were puriﬁed from
pooled normal human serum (obtained from healthy laboratoryblished by Elsevier B.V. All rights reserved.
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bating 10 mg of C3 with 0.1 mg TPCK-treated trypsin (Sigma) for
5 min at room temperature. After inactivation of trypsin by 0.3 mg
soybean trypsin inhibitor (Calbiochem) C3b was puriﬁed with ion ex-
change chromatography [23].
2.2. Bacterial strains, plasmids and bacterial cultivation
The bacterial strains used were S. enterica serovar Typhimurium
14028R (a rough derivative of 14028) [24], S. enterica serovar
Typhimurium 14028R-1 (pgtE-negative derivative of 14028R) [13],
and 14028R-1 and Escherichia coli XL1 (a rough K12-strain; Strata-
gene) complemented with pMRK3 that codes for PgtE [16], with
pMRK31, coding for PgtE D206A which is proteolytically inactive
due to a catalytic site substitution [16], or with the vector plasmid
pSE380 (Invitrogen). To upregulate expression of PgtE, Salmonella
14028R and 14028R-1 were cultivated in PhoP/Q-inducing medium
[13]. PgtE-expression in plasmid-complemented Salmonella 14028R-
1, as well as in recombinant E. coli XL1 was induced by 5 lM IPTG
[19]. After cultivations, the bacteria were collected by centrifugation
and suspended in veronal buﬀered saline for complement cleavage
experiments and in phosphate buﬀered saline for serum sensitivity
experiments.Fig. 1. Proteolytic cleavage of complement components C3b, C4b and
C5 by PgtE-expressing Salmonella enterica. (A) Puriﬁed C3b (above)
and C4b (below) were incubated with S. enterica 14028R, the pgtE-
negative derivative 14028R-1, as well as with 14028R-1 complemented
with the vector pSE380, pMRK3 encoding PgtE, or pMRK31
encoding PgtE D206A for 4 or 22 h. The C3b samples were analyzed
by Western blotting using antibodies against C3c and C3d. C4b
samples were analyzed by using anti-C4c antibodies. Immunoblotting
by the anti-C4c antibodies shows additional, approximately 60 kDa
and 40 kDa, bands, that are presumed to be degradation fragments of2.3. Cleavage of complement proteins C3b, C4b and C5
To study the cleavage of complement components, 2.4 lg of comple-
ment protein C3b, C4b or C5 was incubated in the presence or absence
of 1 · 108 bacterial cells in 60 ll of veronal buﬀered saline at 37 C for
4 or 22 h. To study the eﬀect of plasminogen on bacterium-mediated
C3b cleavage, 3 lg of C3b and 3 lg of human Glu-plasminogen
(American Diagnostica) were incubated with 9 · 107 bacteria in 50 ll
of veronal buﬀered saline for 4 h. As a positive control for the cleavage
of complement proteins, C3b was incubated with factor I and factor H
(10 lg/ml) or with human plasmin (50 lg/ml) (Fluka) and C4b with
factor I (2 lg/ml) and C4bp (1 lg/ml). After incubations, the samples
were centrifuged and supernatants were analyzed by reducing 10%
SDS–PAGE and immunoblotting. The proteins were probed with a
combination of rabbit anti-human C3c and C3d IgG (Dako), rabbit
anti-human C4c (Dako) or rabbit anti-human C5 IgG (Dako). Perox-
idase-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch) was
used as a secondary antibody to detect C3b and C4b cleavage and
alkaline phosphatase-conjugated swine anti-rabbit IgG (Dako) to de-
tect C5 cleavage.
2.4. Serum sensitivity assays
To study the eﬀect of PgtE on bacterial survival in human serum, 1
· 104 bacteria were incubated with 0.5% or 2% normal human serum in
200 ll of phosphate buﬀered saline. Similar incubations were per-
formed in serum incubated at 56 C for 30 min to inactivate the com-
plement system (heat-inactivated serum). After 1- or 4-h incubation at
37 C, dilutions of bacterial suspensions were plated.the C4b preparation used. Complement proteins incubated in buﬀer,
C3b incubated with factor I (fI) and cofactor factor H and C4b
incubated with fI and cofactor C4bp are also shown. Major PgtE-
mediated cleavage products of C3b and C4b are indicated with black
asterisks. (B) Puriﬁed C5 was incubated with S. enterica 14028R,
14028R-1 and 14028R-1(pMRK3) for 22 h. The samples were analyzed
by Western blotting with anti-C5. Migration distances of molecular
weight markers (in kilodaltons) are indicated on the left. On the right,
a, a 0, b and c indicate the polypeptide chains of C3b, C4b and C5.3. Results
3.1. Proteolytic cleavage of complement components
C3b, C4b and C5 by PgtE of S. enterica
Complement components C3b, C4b and C5 are crucial for
the complement cascade [3]. To investigate the ability of S. ent-
erica to cleave these proteins, the complement proteins were
incubated with the bacteria for 4 and 22 h and then analyzed
by immunoblotting. Cleavage of C3b and C4b (Fig. 1A) was
observed with Salmonella 14028R but not with the pgtE-nega-
tive derivative 14028R-1. We used the rough S. enterica
14028R to overcome the steric inhibition of PgtE functions
by the O-antigen [13,16]. Supporting the previous studies
[13,16], derivatives of the smooth Salmonella 14028 failed to
show any proteolytic activity towards C3b or C4b (data not
shown). Complementation of 14082R-1 in trans with the plas-
mid pMRK3, which encodes PgtE, restored degradation ofC3b and C4b. The strain 14028R-1(pMRK31), expressing
PgtE with a catalytic-residue substitution D206A, as well as
14028R-1(pSE380) carrying the plasmid vector, were ineﬃcient
in the cleavage (Fig. 1A).
Degradation of C3b and C4b was also studied with recom-
binant E. coli. The PgtE-expressing E. coli XL1(pMRK3) eﬃ-
ciently degraded C3b and C4b (Fig. 2) whereas XL1(pMRK31)
expressing PgtE D206A and the vector carrying XL1(pSE380)
were inactive. XL1(pMRK3) also cleaved intact C3 and C4
(data not shown). Similarly to PgtE-expressing Salmonella,
Fig. 2. Proteolytic cleavage of complement components C3b and C4b
by recombinant Escherichia coli XL1. Puriﬁed C3b (above) and C4b
(below) were incubated with E. coli XL1 complemented with the vector
plasmid pSE380, pMRK3 encoding PgtE or pMRK31 encoding PgtE
D206A for 22 h. The C3b and C4b samples were analyzed by Western
blotting using antibodies against C3c and C3d or anti-C4c antibodies.
Complement proteins incubated in buﬀer are also shown. Migration
distances of molecular weight markers (in kilodaltons) are indicated on
the left. On the right, a0, b and c indicate the polypeptide chains of C3b
and C4b. Note the complete cleavage of the a 0-chain of C3b and of a 0-
and b-chains of C4b in samples incubated with E. coli XL1(pMRK3).
Fig. 3. The eﬀect of plasminogen on C3b cleavage by Salmonella
enterica. C3b was incubated with S. enterica 14028R and the pgtE-
negative derivative 14028R-1 in the presence (+) or absence () of
plasminogen (Plg). The samples were analyzed by Western blotting
using anti-C3c and anti-C3d antibodies. C3b incubated in buﬀer, with
factor I (fI) and factor H (fH), and with plasmin is also shown. The
black asterisk indicates the 46 kDa peptide formed by Salmonella
14028R, and the 38 kDa peptide formed in the presence of added Plg is
shown by the white asterisk. Migration distances of molecular weight
markers (in kilodaltons) are indicated on the left. On the right, a 0 and b
indicate the polypeptide chains of C3b.
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and 35 kDa fragments (Fig. 2). This fragmentation was partially
similar to the one seen with factor I-mediated cleavage of C3b
(Fig. 1A). In human plasma, factor I together with its cofactor
factor H regulates complement by proteolytically inactivating
C3b into 68 kDa, 46 kDa and 43 kDa fragments [25,26]. On
the other hand, C4b cleavage mediated by factor I and C4bp
or by PgtE was diﬀerent (Fig. 1A). The pgtE-proﬁcient Salmo-
nella 14028R and 14028R-1(pMRK3), but not the pgtE-nega-
tive 14028R-1, also cleaved C5 after 22-h incubation (Fig. 1B),
whereas only weak cleavage was detectable after a 4-h incuba-
tion (data not shown). Also E. coli XL1(pMRK3) degraded
C5 (data not shown). Taken together, these results indicate that
Salmonella PgtE proteolytically cleaves C3b, C4b and C5.Fig. 4. Serum resistance of PgtE-expressing Salmonella enterica and
recombinant Escherichia coli XL1. (A) Survival of Salmonella 14028R
and 14028R-1 in 2% normal human serum was determined by viable
counting after 4-h incubation. Survival of bacteria in serum was
calculated relative to bacterial amount at time point 0 h. The values are
means ± S.D. of two experiments done in triplicate (P < 0.01; Stu-
dent’s two-tailed t-test). Survival of Salmonella 14028R-1 comple-
mented with the PgtE-encoding pMRK3 or the vector plasmid pSE380
in 2% serum (B) and E. coli XL1(pMRK3) and XL1(pSE380) in 0.5%
serum (C) was determined after 1-h incubation.3.2. Proteolytic cleavage of C3b is enhanced by
PgtE-mediated plasminogen activation
Plasmin is a serine protease that degrades many extracellular
matrix components and has also been shown to degrade C3b
[27]. Recently, it was found that proteolytic activation of plas-
minogen to plasmin by staphylokinase of Staphylococcus aur-
eus leads to cleavage of the ﬂuid-phase C3b and decreases
the amount of C3b at the staphylococcal surface [28]. As PgtE
also activates plasminogen [17] we studied the eﬀect of plas-
minogen activation on PgtE-mediated C3b cleavage (Fig. 3).
Adding of plasminogen to suspensions containing 14028R cells
and C3b led to plasmin formation (data not shown) and to for-
mation of an increased amount of the 46 kDa fragment, as well
as production of an additional, c. 38 kDa fragment from C3b
(Fig. 3). A 38 kDa fragment was also seen in C3b incubated
with plasmin (Fig. 3). Salmonella 14028R-1 was ineﬃcient in
C3b cleavage (Fig. 3) and plasminogen activation (data not
shown). These results suggest that PgtE-mediated plasminogen
activation enhances degradation of C3b.3.3. Serum resistance is increased in PgtE-expressing bacteria
Serum resistance of Salmonella involves several aspects of
the cell surface architecture, i.e., the length and irregularity
of the O-antigen [1,29] as well as the cell wall proteins Rck
[30], TraT [31] and PagC [32]. To study the role of PgtE in ser-
um resistance, Salmonella 14028R and 14028R-1 cells were cul-
tured in PhoP/Q-inducing conditions and incubated in 2%
normal human serum. Both Salmonella strains survived and
multiplied during a 4-h incubation (Fig. 4A), however, the
pgtE-proﬁcient 14028R grew signiﬁcantly better than
14028R-1 in the presence of normal human serum. On the
other hand, in heat-inactivated serum both strains grew
equally well (data not shown). This suggests a positive eﬀect
of PgtE on bacterial serum resistance. The PgtE-expressing
Salmonella 14028R-l(pMRK3) which was cultivated in Luria
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better in serum than 14028R-1(pSE380) carrying the vector
plasmid (Fig. 4B). Likewise, survival of the PgtE-expressing
E. coli XL1(pMRK3) in 0.5% serum was better than that of
XL1(pSE380) (Fig. 4C). These results give further evidence
that PgtE has a role in serum resistance of Salmonella.4. Discussion
Our results stress the multifunctional nature of serum resis-
tance in S. enterica. Smooth LPS is a major resistance mecha-
nism of Salmonella against complement attack [11,1]. After
growth within mouse macrophages Typhimurium expresses a
short LPS O-antigen [13] which exposes Salmonella to comple-
ment-mediated killing [11,29]. Salmonella is a facultatively
intracellular pathogen that multiplies both intracellularly and
extracellularly and is continuously released from infected mac-
rophages to infect new ones [33,34]. So, the bacterium is likely
to transiently require alternate mechanisms to the O-antigen
for protection against complement attack. Activity of PgtE is
high in Typhimurium cells released from mouse macrophages,
and our results suggest that PgtE compensates for the loss of
O-antigen and increases serum resistance of Salmonella.
Complement component C3b is an opsonin that induces
bacterial uptake by phagocytes [2]. Salmonella is able to sur-
vive within macrophages and dendritic cells [5], whereas neu-
trophils do not support the growth of Salmonella [35].
Therefore, after release from macrophages it may be important
for Salmonella to cleave and inactivate C3b molecules to pre-
vent uptake by neutrophils. We found that PgtE cleaves C3b
to partially similar fragments as does the C3b-inactivating fac-
tor I [25,26]. It is thus likely that PgtE-mediated cleavage also
leads to inactivation of C3b. Besides opsonization, the inacti-
vation of both C3b and C4b inhibits the formation of comple-
ment activating convertases [2].
PgtE-mediated plasminogen activation and a2-antiplasmin
inactivation are thought to be important mechanisms for Sal-
monella to cause local proteolysis which damages tissue barri-
ers [13,16]. In this study, we found that PgtE-mediated plasmin
formation also increases C3b cleavage. This gives further sup-
port for the view that bacterial interference with the host plas-
minogen system is important during systemic salmonellosis.
PgtE is not the only surface protein of Salmonella that inter-
acts with complement; however, proteolytic degradation of
complement proteins has not been earlier reported with S. enter-
ica. Other surface components that mediate complement resis-
tance in Salmonella include Rck and TraT that prevent
bacteriolysis by inhibiting proper formation of membrane at-
tack complex on the bacterial surface [30,31] and PagC that acts
with a so-far uncharacterizedmechanism [32]. In agreementwith
the multifunctional nature of serum resistance in Salmonella,
both Salmonella 14028R and the pgtE-deﬁcient 14028R-1 sur-
vived in serum after growth under PhoP/Q-inducing conditions.
However, Salmonella 14028R multiplied to signiﬁcantly higher
numbers than 14028R-1. Also overexpression of pgtE in recom-
binant Salmonella andE. coli increased resistance to human ser-
um. Our results thus show that cleavage of complement
components by PgtE promotes serum resistance of Salmonella.
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